Biblio
“Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.”, J Alzheimers Dis, vol. 51, no. 2, pp. 489-500, 2016.
, “Isolated Amyloid-β Pathology Is Associated with Preserved Cortical Plasticity in APOE4 Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 86, no. 2, pp. 773-778, 2022.
, “Hedonic Assessment of Odors: A Comparison of Two Sensory Scales for Use with Alzheimer's Disease Patients and Elderly Individuals.”, J Alzheimers Dis, vol. 61, no. 3, pp. 929-938, 2018.
, “Pain Assessment in Dementia: Evaluation of a Point-of-Care Technological Solution.”, J Alzheimers Dis, vol. 60, no. 1, pp. 137-150, 2017.
, “Preventing Delirium and Promoting Long-Term Brain Health: A Clinical Trial Design for the Perioperative Cognitive Enhancement (PROTECT) Trial.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1637-1649, 2021.
, “Hemochromatosis Mutations, Brain Iron Imaging, and Dementia in the UK Biobank Cohort.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1203-1211, 2021.
, “Our Working Point of View of Tau Protein.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1277-1285, 2018.
, “Internal Consistency Over Time of Subjective Cognitive Decline: Drawing Preclinical Alzheimer's Disease Trajectories.”, J Alzheimers Dis, vol. 66, no. 1, pp. 173-183, 2018.
, “Heterogeneity of Cognitive Anosognosia and its Variation with the Severity of Dementia in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 1, pp. 89-99, 2016.
, “Impact of Social Isolation on People with Dementia and Their Family Caregivers.”, J Alzheimers Dis, vol. 81, no. 2, pp. 607-617, 2021.
, “A Novel Therapeutic Approach to Treat Alzheimer's Disease by Neurotrophic Support During the Period of Synaptic Compensation.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1211-1218, 2018.
, “COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences.”, J Alzheimers Dis, vol. 88, no. 2, pp. 399-416, 2022.
, “Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound.”, J Alzheimers Dis, vol. 58, no. 1, pp. 215-230, 2017.
, “Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1385-1401, 2017.
, “Alzheimer's Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 903-931, 2022.
, “Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases.”, J Alzheimers Dis, vol. 62, no. 1, pp. 247-268, 2018.
, “Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study.”, J Alzheimers Dis, vol. 59, no. 1, pp. 339-358, 2017.
, “Depression and Alzheimer's Disease Biomarkers Predict Driving Decline.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1213-1221, 2018.
, “Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report.”, J Alzheimers Dis, vol. 58, no. 3, pp. 675-680, 2017.
, “A Systematic Review and Meta-Analysis on the Prevalence of Dementia in Europe: Estimates from the Highest-Quality Studies Adopting the DSM IV Diagnostic Criteria.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1471-1481, 2018.
, “What Do We Know About Behavioral Crises in Dementia? A Systematic Review.”, J Alzheimers Dis, vol. 62, no. 1, pp. 99-113, 2018.
, “The Relationships Between Components of Metabolic Syndrome and Mild Cognitive Impairment Subtypes: A Cross-Sectional Study of Japanese Older Adults.”, J Alzheimers Dis, vol. 60, no. 3, pp. 913-921, 2017.
, “Neural Dynamics of Multiple Object Processing in Mild Cognitive Impairment and Alzheimer's Disease: Future Early Diagnostic Biomarkers?”, J Alzheimers Dis, vol. 59, no. 2, pp. 643-654, 2017.
, “Epitomic Characterization of the Specificity of the Anti-Amyloid Aβ Monoclonal Antibodies 6E10 and 4G8.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1235-1244, 2018.
, “General Practice Clinical Data Help Identify Dementia Hotspots: A Novel Geospatial Analysis Approach.”, J Alzheimers Dis, vol. 61, no. 1, pp. 125-134, 2018.
,